Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-15 · accession 0001946439-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-16 | 2023-11-15 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $53.81 | -2,622 | 32.6K | -7% | -$141.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | S | D | 2,622 | $53.81 | 32,587 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $53.80 to $53.91, inclusive. |